Elevated Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Elevated Capital Advisors's AMGN Position: Q3 2026 in Review
Elevated Capital Advisors reduced its Amgen (AMGN) stake by 65% in Q3 2026, selling an estimated $483K and leaving 654 shares worth $276K. The position accounts for 0.09% of the portfolio, ranked #135.
Elevated Capital Advisors first reported a position in AMGN in Q1 2019 and has held it in 18 quarters since. The position peaked at $1.04M in Q1 2026. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Elevated Capital Advisors held 654 shares of Amgen worth $276K as of Q3 2026.
- Elevated Capital Advisors sold 1,211 Amgen shares in Q3 2026, an estimated $483K.
- Amgen made up 0.09% of Elevated Capital Advisors's portfolio in Q3 2026, its #135 holding.
- Elevated Capital Advisors first reported a position in Amgen in Q1 2019 and has held it in 18 quarters since.
- Elevated Capital Advisors's Amgen position peaked at $1.04M in Q1 2026.
- 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Elevated Capital Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.